68Ga-NOTA Evans Blue PET/CT in Patients With Lymphatic System Related Diseases

• Status: Recruiting
• Trial end date: 2024-12-30
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate the potential usefulness of 68Ga-NOTA Evans Blue (68Ga-NEB) positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and efficacy assessment in lymphatic system related diseases.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: First Affiliated Hospital of Fujian Medical University

Criteria

Inclusion Criteria:

• adult population (aged between18 years and 80 years)

• patients with suspected or new diagnosed or previously treated lymphatic system related diseases

• patients who had scheduled 68Ga-NEB PET/CT scan

• patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee

Exclusion Criteria:

• patients with pregnancy

• the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.